# HT血压计 vs 脉理知己

The clearest difference is in-app purchases: HT血压计 at none against 脉理知己's 3. HT血压计 also leads on iOS requirement (8.0 vs 15.6). 脉理知己's advantage is update cadence (every 5 days vs every 3 weeks). On price, ads and device support there is nothing between them.

Both are free to download. 脉理知己 sells 3 in-app purchases, starting at $0.99 per 7 days. HT血压计 asks for nothing beyond the download.

HT血压计 ships an update every 3 weeks, 脉理知己 every 5 days. The most recent releases landed on October 10, 2026 and October 9, 2026 respectively.

## The numbers

| Metric | HT血压计 | 脉理知己 |
| --- | --- | --- |
| Price | Free | Free |
| In-app purchases | **No** | Yes |
| Ads | No | No |
| Update frequency | Every 3 weeks | **Every 5 days** |
| Size | 6 MB | 42 MB |
| Requires iOS | **8.0** | 15.6 |
| Devices | **iPhone, iPad, iPod** | iPhone, iPod |
| Age rating | 4+ | 12+ |
| Developer | [Holtek Semiconductor(China) Inc](https://appshunter.io/developer/1052056181) | [DX CloudData Co., Ltd](https://appshunter.io/developer/1810936300) |

## What reviewers say

### HT血压计

[App page](https://appshunter.io/ios/app/ht/id1167386683)

**In-app purchases:** none


### 脉理知己

[App page](https://appshunter.io/ios/app/and/id6754862042)

**Features:** macOS Compatibility, Vision Pro support

**In-app purchases (3)**

| Purchase | Price | Billing |
| --- | --- | --- |
| 周订阅（特惠） | $0.99 | per 7 days |
| 周订阅 | $6.99 | per 7 days |
| 周订阅 | $6.99 | per 7 days |


## Frequently asked questions

### Is HT血压计 free?

HT血压计 is free to download, with no in-app purchases.

### Is 脉理知己 free?

脉理知己 is free to download, with in-app purchases available.

### Do HT血压计 or 脉理知己 have ads?

Neither HT血压计 nor 脉理知己 shows ads.

### Which is updated more often, HT血压计 or 脉理知己?

HT血压计 ships an update every 3 weeks, and 脉理知己 every 5 days. Most recently, HT血压计 was updated on October 10, 2026 and 脉理知己 on October 9, 2026.

---

*Compared by [AppsHunter](https://appshunter.io/) from daily US App Store data. Review summaries are generated from verbatim App Store reviews.*